Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 9.
doi: 10.1007/s00392-024-02582-4. Online ahead of print.

Eccentric hypertrophy impairs outcome after TAVR

R Thalmann #  1 , V Obermeier #  1   2 , Dominik S Westphal #  3   4   5 , I Diebold  6   7 , T Trenkwalder  2   8 , C Pellegrini  2   8 , G Buglio  1 , H Seoudy  9   10 , P Hoppmann  1 , C Bradaric  1 , U Schön  6 , E Holinski-Feder  6 , N Lettmann  1 , H Ruge  11 , M Erlebach  11 , C Fuetterer  12 , K L Laugwitz  1   2 , M Krane  11 , D Frank  9   10 , C Kupatt  1   2
Affiliations

Eccentric hypertrophy impairs outcome after TAVR

R Thalmann et al. Clin Res Cardiol. .

Abstract

Background: Aortic stenosis (AS) induces cardiac remodeling upon chronic left ventricular (LV) pressure overload. Here, we analyzed the clinical outcome of patients undergoing transcatheter aortic valve replacement (TAVR) for symptomatic AS with regard to varying LV hypertrophy patterns. Moreover, we investigated the genetic influence on development of different hypertrophy patterns, measured by polygenic risk scores (PRS).

Methods: 1703 patients with severe AS undergoing TAVR were categorized according to LV mass index and relative wall thickness in four subgroups: normal geometry (NG, n = 57), concentric remodeling (CR; n = 388), concentric hypertrophy (CH; n = 993) and eccentric hypertrophy (EH; n = 265). Data was analyzed retrospectively with regard to clinical outcome. In a substudy, 520 patients affected by CH (n = 237), EH (n = 139) or CR (n = 164) were analyzed using two PRS that have been previously associated with hypertrophic and dilated cardiomyopathy.

Results: 1 year after TAVR, for EH, in contrast to the remaining groups (NG, CR, CH), a significant difference in all-cause mortality was observable (mortality 17.4% EH, 14.0% NG, 12.4% CR, 14.0% CH, p = 0.001). This difference was observed up to 4 years (mortality 41.9% EH, 26.9% CH, 28.1% CR, 26.4% NG, p = 0.001). Of note, higher percentiles in a PRS for hypertrophic cardiomyopathy were associated with a reduced likelihood of EH in patients with AS (p = 0.046).

Conclusions: The EH group had a statistically significant poorer 1-year and 5-year outcomes than the other groups. PRS might help predict myocardial reactions in patients with aortic stenosis in future.

Keywords: Cardiomyopathy; Hypertrophy; Outcome; Polygenic risk score; TAVR; Transcatheter aortic valve replacement.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors report no competing interests.

References

    1. Lindman BR et al (2016) Calcific aortic stenosis. Nat Rev Dis Primers 2:16006 - DOI - PubMed - PMC
    1. Fairbairn TA et al (2013) Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart 99(16):1185–1191 - DOI - PubMed
    1. Mihl C, Dassen WR, Kuipers H (2008) Cardiac remodelling: concentric versus eccentric hypertrophy in strength and endurance athletes. Neth Heart J 16(4):129–133 - DOI - PubMed - PMC
    1. Hess OM et al (1984) Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 69(5):855–865 - DOI - PubMed
    1. Fitch M (1989) The patient’s reaction to ventilation. Can Crit Care Nurs J 6(2):13–16 - PubMed

LinkOut - more resources